Hyperandrogenism (HA) has been linked with several components of metabolic syndrome (MetS). Few studies in Asian women have evaluated the important risk factors for and prevalence of MetS according to PCOS subtype. In this study, we investigated differences in metabolic parameters and the prevalence of MetS in two major phenotypic subgroups of PCOS in Korea. Furthermore, we investigated the relationship between HA-associated parameters and MetS.This cross-sectional observational study was conducted from May 2010 to December 2011 in Korea. A total of 837 females with PCOS, aged 15–40, were recruited from Departments of Obstetrics and Gynecology at 13 hospitals. Of those, 700 subjects with either polycystic ovaries (PCO)+HA+oligomenorrhea/ame...
Polycystic ovary syndrome (PCOS) is a common endocrinological disorder in female reproductive age. I...
Polycystic ovary syndrome (PCOS) is strongly associated with metabolic abnormalities in Western wome...
Background Female abdominal obesity is associated with hyperandrogenemia (HA), but f...
BACKGROUND: Hyperandrogenism (HA) has been linked with several components of metabolic syndrome (Met...
<div><p>Background</p><p>Hyperandrogenism (HA) has been linked with several components of metabolic ...
Background: Polycystic ovary syndrome (PCOS) is a common condition estimated to affect 5.61% of Chin...
Polycystic ovary syndrome (PCOS) has a heterogeneous phenotypic distribution that can potentially le...
BACKGROUND: Women with polycystic ovary syndrome (PCOS) frequently exhibit central obesity, glucose ...
BACKGROUND: We investigated the differences in anthropometrical, hormonal and insulin resistance par...
Background: Polycystic ovary syndrome (PCOS) increases the risk of metabolic syndrome (MetS). Insuli...
Background: Polycystic ovary syndrome (PCOS) increases the risk of metabolic syndrome (MetS). Insuli...
Polycystic ovary syndrome (PCOS) is a common endocrine disorder that is associated with an increased...
Background: The study evaluated the effect of hyperandrogenism (HA) in polycystic ovary syndrome (PC...
Introduction: The objectives of this study were to provide an estimate of the prevalence of metaboli...
Background: The prevalence of metabolic syndrome (MetS) in polycystic ovary syndrome (PCOS) has bee...
Polycystic ovary syndrome (PCOS) is a common endocrinological disorder in female reproductive age. I...
Polycystic ovary syndrome (PCOS) is strongly associated with metabolic abnormalities in Western wome...
Background Female abdominal obesity is associated with hyperandrogenemia (HA), but f...
BACKGROUND: Hyperandrogenism (HA) has been linked with several components of metabolic syndrome (Met...
<div><p>Background</p><p>Hyperandrogenism (HA) has been linked with several components of metabolic ...
Background: Polycystic ovary syndrome (PCOS) is a common condition estimated to affect 5.61% of Chin...
Polycystic ovary syndrome (PCOS) has a heterogeneous phenotypic distribution that can potentially le...
BACKGROUND: Women with polycystic ovary syndrome (PCOS) frequently exhibit central obesity, glucose ...
BACKGROUND: We investigated the differences in anthropometrical, hormonal and insulin resistance par...
Background: Polycystic ovary syndrome (PCOS) increases the risk of metabolic syndrome (MetS). Insuli...
Background: Polycystic ovary syndrome (PCOS) increases the risk of metabolic syndrome (MetS). Insuli...
Polycystic ovary syndrome (PCOS) is a common endocrine disorder that is associated with an increased...
Background: The study evaluated the effect of hyperandrogenism (HA) in polycystic ovary syndrome (PC...
Introduction: The objectives of this study were to provide an estimate of the prevalence of metaboli...
Background: The prevalence of metabolic syndrome (MetS) in polycystic ovary syndrome (PCOS) has bee...
Polycystic ovary syndrome (PCOS) is a common endocrinological disorder in female reproductive age. I...
Polycystic ovary syndrome (PCOS) is strongly associated with metabolic abnormalities in Western wome...
Background Female abdominal obesity is associated with hyperandrogenemia (HA), but f...